The company ended the quarter with $529 million in cash equivalents and marketable securities and no debt outstanding. Marotta said Azenta completed its first customer deployment of an AI-enabled biorepository inventory solution featuring advanced imaging and data-management capabilities. Automated Stores remained below prior-year levels, though Azenta added new opportunities to its backlog during the quarter. Guidance raised following third-quarter performanceFollowing the stronger-than-expected quarter, Azenta raised its fiscal 2026 revenue outlook. Marotta said Azenta will provide its fiscal 2027 outlook after reporting fiscal 2026 year-end results in November.